<DOC>
	<DOCNO>NCT00264472</DOCNO>
	<brief_summary>5 fluorouracil ( 5 FU ) , one actively investigate anti-cancer drug , rapidly inactivate enzyme dihydropyrimidine dehydrogenase ( DPD ) . ADH300004 block DPD . This study test safety effect oral ADH300004 14 hour prior oral 5 FU subject refractory solid tumor .</brief_summary>
	<brief_title>A Study 5 Fluorouracil Anti-Tumor Activity ADH300004 5 Fluorouracil Subjects With Incurable Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Eniluracil</mesh_term>
	<criteria>Signed write informed consent &gt; = 18 year age Advanced metastatic solid tumor : Part 1 : Histologically proven advanced metastatic solid tumor refractory standard therapy standard therapy exist Part 2 : Histologically proven advanced and/or metastatic solid tumor one follow 6 histology , refractory standard curative therapy curative therapy exists : HCC , NSCLC , gastric cancer , cervical cancer , prostate cancer , breast cancer Radiologically document measurable evaluable ( nonmeasurable ) disease Adequate performance status organ function , evidence hematologic biochemical blood test Willing receive fluoropyrimidine contain chemotherapy 8 week last dose ADH300004 study Cytotoxic chemotherapy , radiotherapy , investigational drug within 28 day prior study entry Noncytotoxic cancer therapy within 14 day prior study entry Portal hypertension bleed esophageal gastric varix within past 3 month Ascites refractory conservative management Inability take oral medication Active peptic ulcer disease Known hypersensitivity 5FU ADH300004 Stroke , major surgery , major tissue injury within 30 day study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Tumors</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Anticarcinogenic Agents</keyword>
	<keyword>Antineoplastic Agents</keyword>
	<keyword>Dihydrouracil Dehydrogenase ( NADP )</keyword>
</DOC>